Asymptomatic Moyamoya Disease

Satoshi Kuroda

doi:10.1007/978-981-33-6404-2_12

Asymptomatic Moyamoya Disease

Satoshi Kuroda^*

^*この論文の責任著者

脳神経外科学講座

研究成果: 書籍の章/レポート/会議録 › 章 › 査読

1 被引用数 (Scopus)

抄録

The pathogenesis, prognosis, and treatment strategy of asymptomatic moyamoya disease is still obscure. In this chapter, our knowledge is summarized by reviewing previous articles on asymptomatic moyamoya disease. Then, the results of previous small-volume cohort studies on asymptomatic moyamoya disease are reviewed, and the on-going multicenter observational study in Japan (AMORE Study) is also described.

本文言語	英語
ホスト出版物のタイトル	Moyamoya Disease
ホスト出版物のサブタイトル	Current Knowledge and Future Perspectives
出版社	Springer Singapore
ページ	143-152
ページ数	10
ISBN（電子版）	9789813364042
ISBN（印刷版）	9789813364035
DOI	https://doi.org/10.1007/978-981-33-6404-2_12
出版ステータス	出版済み - 2021/01/01

ASJC Scopus 主題領域

医学一般

文献へのアクセス

10.1007/978-981-33-6404-2_12

引用スタイル

@inbook{80ca88999df2436ca2458517733aad78,

title = "Asymptomatic Moyamoya Disease",

abstract = "The pathogenesis, prognosis, and treatment strategy of asymptomatic moyamoya disease is still obscure. In this chapter, our knowledge is summarized by reviewing previous articles on asymptomatic moyamoya disease. Then, the results of previous small-volume cohort studies on asymptomatic moyamoya disease are reviewed, and the on-going multicenter observational study in Japan (AMORE Study) is also described.",

keywords = "Asymptomatic moyamoya disease, Cerebral blood flow, Cerebral infarct, Microbleed, Multicenter observational study, Outcome, Risk, Stroke",

author = "Satoshi Kuroda",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2021.",

year = "2021",

month = jan,

day = "1",

doi = "10.1007/978-981-33-6404-2_12",

language = "英語",

isbn = "9789813364035",

pages = "143--152",

booktitle = "Moyamoya Disease",

publisher = "Springer Singapore",

}

TY - CHAP

T1 - Asymptomatic Moyamoya Disease

AU - Kuroda, Satoshi

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2021.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - The pathogenesis, prognosis, and treatment strategy of asymptomatic moyamoya disease is still obscure. In this chapter, our knowledge is summarized by reviewing previous articles on asymptomatic moyamoya disease. Then, the results of previous small-volume cohort studies on asymptomatic moyamoya disease are reviewed, and the on-going multicenter observational study in Japan (AMORE Study) is also described.

AB - The pathogenesis, prognosis, and treatment strategy of asymptomatic moyamoya disease is still obscure. In this chapter, our knowledge is summarized by reviewing previous articles on asymptomatic moyamoya disease. Then, the results of previous small-volume cohort studies on asymptomatic moyamoya disease are reviewed, and the on-going multicenter observational study in Japan (AMORE Study) is also described.

KW - Asymptomatic moyamoya disease

KW - Cerebral blood flow

KW - Cerebral infarct

KW - Microbleed

KW - Multicenter observational study

KW - Outcome

KW - Risk

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85134525340&partnerID=8YFLogxK

U2 - 10.1007/978-981-33-6404-2_12

DO - 10.1007/978-981-33-6404-2_12

M3 - 章

AN - SCOPUS:85134525340

SN - 9789813364035

SP - 143

EP - 152

BT - Moyamoya Disease

PB - Springer Singapore

ER -

Asymptomatic Moyamoya Disease

抄録

ASJC Scopus 主題領域

文献へのアクセス

フィンガープリント

引用スタイル